| Request Type |
Registration
|
|---|---|
| Drug Type |
Generic
|
| Trade Name |
Alatript
|
| Scientific Name |
Amitriptyline Hydrochloride
|
| Strength |
10 mg
|
| Dosage Form |
Film-coated tablet
|
| Approval Date |
|
| SFDA Approved Use |
Amitriptyline is indicated for:
1. The treatment of major depressive disorder in adults 2. The treatment of neuropathic pain in adults 3. The prophylactic treatment of chronic tension type headache (CTTH) in adults 4. The prophylactic treatment of migraine in adults 5. The treatment of nocturnal enuresis in children aged 6 years and above when organic pathology, including spina bifida and related disorders, have been excluded and no response has been achieved to all other non-drug and drug treatments, including antispasmodics and vasopressin-related products. This medicinal product should be prescribed by a healthcare professional with expertise in the management of persistent enuresis |
An official government website affiliated with the Government of the Kingdom of Saudi Arabia.
Sun 15 Nov 2026
Beta version
Official Saudi government website domains end with gov.sa
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
Official Reliable websites use HTTPS
Ensure the website is using the HTTPS protocol.
Registered with the Digital Government Authority under number:
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.